Will Spooren

Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche

Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.

From this contributor

Spectrum from The Transmitter.
Spectrum

Questions for Will Spooren: Paving a path to autism drugs

By Ingrid Wickelgren
13 October 2015 | 6 min read

Explore more from The Transmitter

Research image of proliferating neural cells.
Spectrum

Diverse autism genes derail common developmental pathways

Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.

By Holly Barker
8 July 2026 | 5 min read
Brain scans showing sex-based activation differences.
Sex differences

Brain’s sex differences are subtle and contradictory, large MRI study finds

Sex-based behavioral differences do not match with variations in brain activation or structure in a study of almost 1,000 people.

By Lauren Schenkman
8 July 2026 | 5 min read
Research image of autism-linked gene PTEN changes in neurons.
Spectrum

A consensus on the definition of profound autism, and more

Here is a roundup of autism-related news and research spotted around the web for the week of 5 July.

By Sarah Thau
7 July 2026 | 2 min read